Profile: Ucb S.A. is involved in research, development & distribution of pharmaceutical & biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune & inflammatory disorders and oncology. Our Xyzal® is an antihistamine treatment for symptoms associated with allergic conditions such as seasonal allergic rhinitis, perennial allergic rhinitis and chronic idiopathic urticaria.